Drug intelligence / Profile preview

sodium chloride + yellow fever virus strain 17d-204 live antigen

Development stage
Unknown
Lead developer
Sanofi Pasteur
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

This product is a **combination formulation** consisting of live attenuated **yellow fever virus strain 17D-204 live antigen** together with its accompanying **sodium chloride diluent** used for reconstitution prior to administration. It corresponds to the YF-VAX presentation supplied as a lyophilized live-virus vaccine plus preservative-free sterile sodium chloride injection. The biologically active component is the 17D-204 yellow fever vaccine virus, a live attenuated flavivirus antigen developed by **Sanofi Pasteur** to prevent **yellow fever**. After administration, the vaccine induces humoral and cellular immune responses, with protective activity primarily associated with generation of neutralizing antibodies against yellow fever viral envelope antigens. The sodium chloride component functions as a reconstitution diluent rather than as a therapeutic active ingredient.

Other names
sodium chloride + yellow fever virus strain 17d-204 live antigenyellow fever vaccine live with sodium chloride diluentyellow fever vaccine 17D-204 with sodium chloride diluent

Beyond the preview

Go deeper on sodium chloride + yellow fever virus strain 17d-204 live antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride + yellow fever virus strain 17d-204 live antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call